Potentials of Interferons and Hydroxychloroquine for the Prophylaxis and Early Treatment of COVID-19
Article
[키워드] Activation
activation of inflammasome
acute respiratory distress
Adaptive immune response
ARDS
Asymptomatic
benefit
cause
cells
clinical study
COVID-19
disease
early stage
eventually death
exacerbated
failure
hallmark
HCQ
Hydroxychloroquine
hyperinflammatory state
IFN
IFN response
induce
Infection
Inflammatory cytokines
Inflammatory response
inhibit
interferon
ISGs
Mild
mild cases
molecular mechanism
Mortality
NFκB
NLRP3
obesity
ongoing trial
pandemic of COVID-19
Postexposure Prophylaxis
Potential
progression
Prophylaxis
randomized clinical trial
RCTs
responsible
risk factor
Severe case
severe COVID-19
severe disease
shown
stimulate
stimulated
Symptom
syndrome
tissue damage
transcription factor
Treatment
Type
type I
Type III IFN
understanding
viral entry
Viral load
[DOI] 10.33696/immunology.2.063 PMC 바로가기 [Article Type] Article
[DOI] 10.33696/immunology.2.063 PMC 바로가기 [Article Type] Article